Global Needle Free Injection System Growing Rapidly at CAGR of 14.7% By 2030
Category : Medical Devices | Published Date : Jul 2024
Needle Free Injection System Market Scope & Overview:
The needle-free injection system delivers medication into the body without a needle, using high-pressure fluid to penetrate the skin. It's cost-effective and endorsed by the World Health Organization, addressing challenges related to needle reuse and injuries. This technology has a wide range of applications, from liquid formulations to drugs and vaccines in solid dosage forms.
Consegic Business Intelligence analyzes that the Global Needle Free Injection System Market size was valued at USD 16,340 Million in 2022 and is expected to register a CAGR of 14.7% to reach USD 48,515.83 Million by 2030.
This report comprises Needle Free Injection System Market Share, Size & Industry Analysis, By Product (Fillable and Prefilled), By Usability (Disposable and Reusable), By Application (Vaccine Delivery, Insulin Delivery, Pain Management, and Others), By End User (Hospitals & Clinics, Home Care Settings, Research Laboratories, and Others), By Region (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa), and Forecast, 2023-2030.
This report contains detailed information on Needle Free Injection System Market Opportunities, Trends, Value, Growth Rate, Segmentation, Geographical Coverage, Company Profile, In-depth Expert Analysis, Revenue Forecast, Competitive Landscape, Growth Factors, Restraint or Challenges, Environment & Regulatory Landscape, PESTLE Analysis, PORTER Analysis, Key Technology Landscape, Value Chain Analysis, and Cost Analysis.
As per the report analysis, the market for needle free injection system market is growing due to the high risk of needle stick injuries and patient reluctance to use conventional needles. The needle-free injectable system is a safe method of drug delivery that eliminates the risk of infectious diseases. It offers advantages such as low drug dosage requirement, site-specific drug delivery, and minimized hospital stays.
Segmental Analysis :
The Needle Free Injection System Market is segmented based on product, usability, application, end user, and region.
Based on the product, the market is bifurcated into Fillable and Prefilled.
- In the year 2022, the fillable segment comprised the largest share of the market and is expected to grow at the fastest CAGR during the forecasted period. The fillable-based needle-free injection system is extensively used due to its eco-friendly characteristics. They are widely accessible and exhibit a high level of acceptance in the market.
Based on the usability, the market is bifurcated into Disposable and Reusable.
- In the year 2022, the disposable segment held the highest market share in the overall market and is projected to witness the fastest CAGR over the forecasted period. These types of needles are extensively used for drawing blood samples and administering vaccines, contributing to their widespread adoption in the healthcare industry.
Based on the application, the market is divided into Vaccine Delivery, Insulin Delivery, Pain Management, and Others.
- In 2022, the vaccine delivery segment held the highest market share at 41.05% in the market. This was due to the increasing cases of chronic diseases globally, rising demand for self-injectable devices, mass vaccination campaigns, and increasing demand for pediatric patients.
- The pain management segment is expected to grow at the fastest rate in the market due to increasing cases of medical conditions such as arthritis, pain disorders, migraine, tension headaches, cluster headaches, and migraine globally.
Based on the end user, the market is segregated into Hospitals & Clinics, Home Care Settings, Research Laboratories, and Others.
- In 2022, hospitals and clinics accounted for the highest market share in the overall market and are expected to grow at the fastest rate. The rising number of hospitals globally, technological advancements, and the increasing demand for vaccinations are driving this trend.
By region, the market is segregated into regions including North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
- In 2022, North America had the highest market share of 36.10%, valued at USD 5,898.74 million, and is expected to reach USD 17,586.99 million in 2030. The U.S. accounted for the highest market share of 65.15% in 2022. The demand for systems in North America is driven by the presence of market players, developed healthcare systems, and the rising number of chronic diseases.
- Asia Pacific is expected to grow at the fastest CAGR of 15.4% during the forecast period due to government initiatives and increased healthcare expenditure, driving the market growth in the region.
| Report Attributes | Report Details |
| By Product | Fillable and Prefilled |
| By Usability | Disposable and Reusable |
| By Application | Vaccine Delivery, Insulin Delivery, Pain Management, and Others |
| By End User | Hospitals & Clinics, Home Care Settings, Research Laboratories, and Others |
| By Region | North America(U.S., Canada, Mexico) Europe(U.K., Germany, France, Spain, Italy, Russia, Benelux, Rest of Europe) APAC(China, South Korea, Japan, India, Australia, ASEAN, Rest of Asia-Pacific) Middle East & Africa(GCC, Turkey, South Africa, Rest of MEA) LATAM(Brazil, Argentina, Chile, Rest of LATAM) |
Top Key Players & Competitive Landscape :
The competitive landscape encompasses major innovators, aftermarket service providers, industry giants, and niche players, all of which are thoroughly examined by Consegic Business Intelligence in terms of their strengths, weaknesses, and value-addition potential. This report includes detailed profiles of key players, market share analysis, mergers and acquisitions, resulting market fragmentation, and emerging partnership trends and dynamics.
List of prominent players in the Needle Free Injection System Industry :
- Terumo Corporation
- Pulse NeedleFree
- PharmaJet
- Portal Instruments
- Medical International Technology Inc
- NuGen Medical Devices
- Crossject
- Inovio Pharmaceuticals
- Antares Pharma, Inc
- Penjet Corporation
Recent Industry Developments :
- In December 2022, Terumo Corporation launched G-Lasta Subcutaneous Injection 3.6 mg BodyPod in collaboration with Kyowa Kirin Co. Ltd. This drug-device combination product features an automated injection device developed by Terumo.
- In April 2022, PharmaJet introduced an enhanced, interactive website providing improved access to needle-free data and applications.